{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:56:45Z","timestamp":1791845805749,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,3,15]],"date-time":"2015-03-15T00:00:00Z","timestamp":1426377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s11481-015-9598-9","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T05:53:20Z","timestamp":1426312400000},"page":"506-516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems"],"prefix":"10.1007","volume":"10","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-fan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-fan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Uzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng-hai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,15]]},"reference":[{"key":"9598_CR1","author":"AA Abdin","year":"2014","unstructured":"Abdin AA, Hasby EA (2014) Modulatory effect of celastrol on Th1\/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats. Eur J Pharmacol. doi: 10.1016\/j.ejphar.2014.09.001","journal-title":"Eur J Pharmacol"},{"key":"9598_CR2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0278-5846(01)00192-0","volume":"25","author":"AC Allison","year":"2001","unstructured":"Allison AC, Cacabelos R, Lombardi VR, Alvarez XA, Vigo C (2001) Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 25:1341\u20131357","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9598_CR3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ni1430","volume":"8","author":"SL Bailey","year":"2007","unstructured":"Bailey SL, Schreiner B, McMahon EJ, Miller SD (2007) CNS myeloid DCs presenting endogenous myelin peptides \u2018preferentially\u2019 polarize CD4+ T(H)-17 cells in relapsing EAE. Nat Immunol 8:172\u2013180. doi: 10.1038\/ni1430","journal-title":"Nat Immunol"},{"key":"9598_CR4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235\u2013238. doi: 10.1038\/nature04753","journal-title":"Nature"},{"key":"9598_CR5","doi-asserted-by":"crossref","first-page":"e94733","DOI":"10.1371\/journal.pone.0094733","volume":"9","author":"FJ Carrillo-Salinas","year":"2014","unstructured":"Carrillo-Salinas FJ et al (2014) A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis. PLoS One 9:e94733. doi: 10.1371\/journal.pone.0094733","journal-title":"PLoS One"},{"key":"9598_CR6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMe0912019","volume":"362","author":"WM Carroll","year":"2010","unstructured":"Carroll WM (2010) Oral therapy for multiple sclerosis\u2013sea change or incremental step? N Engl J Med 362:456\u2013458. doi: 10.1056\/NEJMe0912019","journal-title":"N Engl J Med"},{"key":"9598_CR7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.1014154108","volume":"108","author":"JW Choi","year":"2011","unstructured":"Choi JW et al (2011) FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc Natl Acad Sci U S A 108:751\u2013756. doi: 10.1073\/pnas.1014154108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9598_CR8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","volume":"33","author":"J Chun","year":"2010","unstructured":"Chun J, Hartung HP (2010) Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol 33:91\u2013101. doi: 10.1097\/WNF.0b013e3181cbf825","journal-title":"Clin Neuropharmacol"},{"key":"9598_CR9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","volume":"30","author":"Y Chung","year":"2009","unstructured":"Chung Y et al (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30:576\u2013587. doi: 10.1016\/j.immuni.2009.02.007","journal-title":"Immunity"},{"key":"9598_CR10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1352458509357065","volume":"16","author":"G Comi","year":"2010","unstructured":"Comi G et al (2010) Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results. Mult Scler 16:197\u2013207. doi: 10.1177\/1352458509357065","journal-title":"Mult Scler"},{"key":"9598_CR11","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502\u20131517. doi: 10.1016\/s0140-6736(08)61620-7","journal-title":"Lancet"},{"key":"9598_CR12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164:1079\u20131106. doi: 10.1111\/j.1476-5381.2011.01302.x","journal-title":"Br J Pharmacol"},{"key":"9598_CR13","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua DJ et al (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744\u2013748. doi: 10.1038\/nature01355","journal-title":"Nature"},{"key":"9598_CR14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/icb.2008.26","volume":"86","author":"SS Diebold","year":"2008","unstructured":"Diebold SS (2008) Determination of T-cell fate by dendritic cells. Immunol Cell Biol 86:389\u2013397. doi: 10.1038\/icb.2008.26","journal-title":"Immunol Cell Biol"},{"key":"9598_CR15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nri2295","volume":"8","author":"C Dong","year":"2008","unstructured":"Dong C (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8:337\u2013348. doi: 10.1038\/nri2295","journal-title":"Nat Rev Immunol"},{"key":"9598_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cyto.2009.12.003","volume":"50","author":"LJ Edwards","year":"2010","unstructured":"Edwards LJ, Robins RA, Constantinescu CS (2010) Th17\/Th1 phenotype in demyelinating disease. Cytokine 50:19\u201323. doi: 10.1016\/j.cyto.2009.12.003","journal-title":"Cytokine"},{"key":"9598_CR17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4103\/1673-5374.131572","volume":"9","author":"C Engelmann","year":"2014","unstructured":"Engelmann C, Weih F, Haenold R (2014) Role of nuclear factor kappa B in central nervous system regeneration. Neural Regen Res 9:707\u2013711. doi: 10.4103\/1673-5374.131572","journal-title":"Neural Regen Res"},{"key":"9598_CR18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/jnc.12781","volume":"130","author":"B Eroglu","year":"2014","unstructured":"Eroglu B et al (2014) Therapeutic inducers of the HSP70\/HSP110 protect mice against traumatic brain injury. J Neurochem 130:626\u2013641. doi: 10.1111\/jnc.12781","journal-title":"J Neurochem"},{"key":"9598_CR19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2202-10-109","volume":"10","author":"K Faust","year":"2009","unstructured":"Faust K, Gehrke S, Yang Y, Yang L, Beal MF, Lu B (2009) Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson\u2019s disease. BMC Neurosci 10:109. doi: 10.1186\/1471-2202-10-109","journal-title":"BMC Neurosci"},{"key":"9598_CR20","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1182\/blood-2009-03-209932","volume":"114","author":"L Gilles","year":"2009","unstructured":"Gilles L et al (2009) MAL\/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9. Blood 114:4221\u20134232. doi: 10.1182\/blood-2009-03-209932","journal-title":"Blood"},{"key":"9598_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.58.2.169","volume":"58","author":"DS Goodin","year":"2002","unstructured":"Goodin DS et al (2002) Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 58:169\u2013178","journal-title":"Neurology"},{"key":"9598_CR22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","volume":"9","author":"J Goverman","year":"2009","unstructured":"Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393\u2013407. doi: 10.1038\/nri2550","journal-title":"Nat Rev Immunol"},{"key":"9598_CR23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm1197","volume":"11","author":"M Greter","year":"2005","unstructured":"Greter M et al (2005) Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 11:328\u2013334. doi: 10.1038\/nm1197","journal-title":"Nat Med"},{"key":"9598_CR24","author":"D Harari","year":"2014","unstructured":"Harari D et al (2014) Enhanced In Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis. J Biol Chem. doi: 10.1074\/jbc.M114.602474","journal-title":"J Biol Chem"},{"key":"9598_CR25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2207","volume":"13","author":"G Huang","year":"2012","unstructured":"Huang G, Wang Y, Vogel P, Kanneganti TD, Otsu K, Chi H (2012) Signaling via the kinase p38alpha programs dendritic cells to drive TH17 differentiation and autoimmune inflammation. Nat Immunol 13:152\u2013161. doi: 10.1038\/ni.2207","journal-title":"Nat Immunol"},{"key":"9598_CR26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1183021","volume":"327","author":"A Iwasaki","year":"2010","unstructured":"Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327:291\u2013295. doi: 10.1126\/science.1183021","journal-title":"Science"},{"key":"9598_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2010.10.025","volume":"303","author":"R Kannaiyan","year":"2011","unstructured":"Kannaiyan R, Shanmugam MK, Sethi G (2011) Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer. Cancer Lett 303:9\u201320. doi: 10.1016\/j.canlet.2010.10.025","journal-title":"Cancer Lett"},{"key":"9598_CR28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir H et al (2007) Human TH17 lymphocytes promote blood\u2013brain barrier disruption and central nervous system inflammation. Nat Med 13:1173\u20131175. doi: 10.1038\/nm1651","journal-title":"Nat Med"},{"key":"9598_CR29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000090364","volume":"2","author":"M Kiaei","year":"2005","unstructured":"Kiaei M, Kipiani K, Petri S, Chen J, Calingasan NY, Beal MF (2005) Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis 2:246\u2013254. doi: 10.1159\/000090364","journal-title":"Neurodegener Dis"},{"key":"9598_CR30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2362.2009.02186.x","volume":"39","author":"DH Kim","year":"2009","unstructured":"Kim DH, Shin EK, Kim YH, Lee BW, Jun JG, Park JH, Kim JK (2009a) Suppression of inflammatory responses by celastrol, a quinone methide triterpenoid isolated from Celastrus regelii. Eur J Clin Invest 39:819\u2013827. doi: 10.1111\/j.1365-2362.2009.02186.x","journal-title":"Eur J Clin Invest"},{"key":"9598_CR31","unstructured":"Kim DY, Park JW, Jeoung D, Ro JY (2009b) Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model. Eur J Pharmacol 612:98\u2013105. doi: 10.1016\/j.ejphar.2009.03.078S0014-2999(09)00311-2"},{"key":"9598_CR32","doi-asserted-by":"crossref","first-page":"e62068","DOI":"10.1371\/journal.pone.0062068","volume":"8","author":"JE Kim","year":"2013","unstructured":"Kim JE et al (2013) Celastrol, an NF-kappaB inhibitor, improves insulin resistance and attenuates renal injury in db\/db mice. PLoS One 8:e62068. doi: 10.1371\/journal.pone.0062068","journal-title":"PLoS One"},{"key":"9598_CR33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","volume":"177","author":"Y Komiyama","year":"2006","unstructured":"Komiyama Y et al (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177:566\u2013573","journal-title":"J Immunol"},{"key":"9598_CR34","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/eji.1830260735","volume":"26","author":"M Krakowski","year":"1996","unstructured":"Krakowski M, Owens T (1996) Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 26:1641\u20131646. doi: 10.1002\/eji.1830260735","journal-title":"Eur J Immunol"},{"key":"9598_CR35","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.179.3.1423","volume":"179","author":"I Kryczek","year":"2007","unstructured":"Kryczek I, Wei S, Vatan L, Escara-Wilke J, Szeliga W, Keller ET, Zou W (2007) Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. J Immunol 179:1423\u20131426","journal-title":"J Immunol"},{"key":"9598_CR36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL et al (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233\u2013240. doi: 10.1084\/jem.20041257","journal-title":"J Exp Med"},{"key":"9598_CR37","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bcp.2006.08.014","volume":"72","author":"JH Lee","year":"2006","unstructured":"Lee JH et al (2006) Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid. Biochem Pharmacol 72:1311\u20131321. doi: 10.1016\/j.bcp.2006.08.014","journal-title":"Biochem Pharmacol"},{"key":"9598_CR38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jep.2008.05.028","volume":"118","author":"H Li","year":"2008","unstructured":"Li H, Zhang YY, Tan HW, Jia YF, Li D (2008) Therapeutic effect of tripterine on adjuvant arthritis in rats. J Ethnopharmacol 118:479\u2013484. doi: 10.1016\/j.jep.2008.05.028","journal-title":"J Ethnopharmacol"},{"key":"9598_CR39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","volume":"8","author":"C Lock","year":"2002","unstructured":"Lock C et al (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500\u2013508. doi: 10.1038\/nm0502-500","journal-title":"Nat Med"},{"key":"9598_CR40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nm1202","volume":"11","author":"EJ McMahon","year":"2005","unstructured":"McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD (2005) Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 11:335\u2013339. doi: 10.1038\/nm1202","journal-title":"Nat Med"},{"key":"9598_CR41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s11481-013-9453-9","volume":"8","author":"RC McPherson","year":"2013","unstructured":"McPherson RC, Anderton SM (2013) Adaptive immune responses in CNS autoimmune disease: mechanisms and therapeutic opportunities. J Neuroimmune Pharmacol 8:774\u2013790. doi: 10.1007\/s11481-013-9453-9","journal-title":"J Neuroimmune Pharmacol"},{"key":"9598_CR42","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","volume":"38","author":"KH Mills","year":"2008","unstructured":"Mills KH (2008) Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 38:2636\u20132649. doi: 10.1002\/eji.200838535","journal-title":"Eur J Immunol"},{"key":"9598_CR43","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","volume":"198","author":"CA Murphy","year":"2003","unstructured":"Murphy CA et al (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951\u20131957. doi: 10.1084\/jem.20030896","journal-title":"J Exp Med"},{"key":"9598_CR44","doi-asserted-by":"crossref","first-page":"22216","DOI":"10.1074\/jbc.M112.356816","volume":"287","author":"SM Nanjundaiah","year":"2012","unstructured":"Nanjundaiah SM, Venkatesha SH, Yu H, Tong L, Stains JP, Moudgil KD (2012) Celastrus and its bioactive celastrol protect against bone damage in autoimmune arthritis by modulating osteoimmune cross-talk. J Biol Chem 287:22216\u201322226. doi: 10.1074\/jbc.M112.356816","journal-title":"J Biol Chem"},{"key":"9598_CR45","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133\u20131141. doi: 10.1038\/ni1261","journal-title":"Nat Immunol"},{"key":"9598_CR46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1476-4598-9-79","volume":"9","author":"B Peng","year":"2010","unstructured":"Peng B, Xu L, Cao F, Wei T, Yang C, Uzan G, Zhang D (2010) HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0\/G1 in thiol-containing agents reversible way. Mol Cancer 9:79. doi: 10.1186\/1476-4598-9-79","journal-title":"Mol Cancer"},{"key":"9598_CR47","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","volume":"50","author":"JW Peterson","year":"2001","unstructured":"Peterson JW, Bo L, Mork S, Chang A, Trapp BD (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389\u2013400","journal-title":"Ann Neurol"},{"key":"9598_CR48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-pathol-011811-132443","volume":"7","author":"BF Popescu","year":"2012","unstructured":"Popescu BF, Lucchinetti CF (2012) Pathology of demyelinating diseases. Annu Rev Pathol 7:185\u2013217. doi: 10.1146\/annurev-pathol-011811-132443","journal-title":"Annu Rev Pathol"},{"key":"9598_CR49","first-page":"901","volume":"19","author":"BF Popescu","year":"2013","unstructured":"Popescu BF, Pirko I, Lucchinetti CF (2013) Pathology of multiple sclerosis: where do we stand? Continuum (Minneapolis, Minn) 19:901\u2013921. doi: 10.1212\/01.con.0000433291.23091.65","journal-title":"Continuum (Minneapolis, Minn)"},{"key":"9598_CR50","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2006-10-050807","volume":"109","author":"G Sethi","year":"2007","unstructured":"Sethi G, Ahn KS, Pandey MK, Aggarwal BB (2007) Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Blood 109:2727\u20132735. doi: 10.1182\/blood-2006-10-050807","journal-title":"Blood"},{"key":"9598_CR51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","volume":"24","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179\u2013189. doi: 10.1016\/j.immuni.2006.01.001","journal-title":"Immunity"},{"key":"9598_CR52","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1016\/j.bmc.2012.06.050","volume":"20","author":"SH Venkatesha","year":"2012","unstructured":"Venkatesha SH, Astry B, Nanjundaiah SM, Yu H, Moudgil KD (2012) Suppression of autoimmune arthritis by Celastrus-derived Celastrol through modulation of pro-inflammatory chemokines. Bioorg Med Chem 20:5229\u20135234. doi: 10.1016\/j.bmc.2012.06.050","journal-title":"Bioorg Med Chem"},{"key":"9598_CR53","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.4049\/jimmunol.158.11.5507","volume":"158","author":"K Vermeire","year":"1997","unstructured":"Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P (1997) Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol 158:5507\u20135513","journal-title":"J Immunol"},{"key":"9598_CR54","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1097\/CCM.0b013e3181f17bcb","volume":"38","author":"Y Wan","year":"2010","unstructured":"Wan Y et al (2010) Cognitive decline following major surgery is associated with gliosis, beta-amyloid accumulation, and tau phosphorylation in old mice. Crit Care Med 38:2190\u20132198. doi: 10.1097\/CCM.0b013e3181f17bcb","journal-title":"Crit Care Med"},{"key":"9598_CR55","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1523\/JNEUROSCI.4936-13.2014","volume":"34","author":"X Wang","year":"2014","unstructured":"Wang X, Cattaneo F, Ryno L, Hulleman J, Reixach N, Buxbaum JN (2014) The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer\u2019s disease model mice. J Neurosci: Off J Soc Neurosci 34:7253\u20137265. doi: 10.1523\/jneurosci. 4936-13.2014","journal-title":"J. Neurosci.: Off J Soc Neurosci"},{"key":"9598_CR56","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1476-5381.2009.00292.x","volume":"157","author":"F Wu","year":"2009","unstructured":"Wu F, Han M, Wilson JX (2009) Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation. Br J Pharmacol 157:1014\u20131023. doi: 10.1111\/j.1476-5381.2009.00292.x","journal-title":"Br J Pharmacol"},{"key":"9598_CR57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","volume":"356","author":"TA Yednock","year":"1992","unstructured":"Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356:63\u201366. doi: 10.1038\/356063a0","journal-title":"Nature"},{"key":"9598_CR58","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.it.2011.02.007","volume":"32","author":"J Zepp","year":"2011","unstructured":"Zepp J, Wu L, Li X (2011) IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol 32:232\u2013239. doi: 10.1016\/j.it.2011.02.007","journal-title":"Trends Immunol"},{"key":"9598_CR59","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1189\/jlb.1005611","volume":"80","author":"DH Zhang","year":"2006","unstructured":"Zhang DH et al (2006) Tripterine inhibits the expression of adhesion molecules in activated endothelial cells. J Leukoc Biol 80:309\u2013319. doi: 10.1189\/jlb.1005611","journal-title":"J Leukoc Biol"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-015-9598-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-015-9598-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-015-9598-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T20:12:17Z","timestamp":1691525537000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-015-9598-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,15]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["9598"],"URL":"https:\/\/doi.org\/10.1007\/s11481-015-9598-9","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,15]]}}}